Search Results - "Trico, D"

Comparison of a purely endoscopic three-layer technique versus pericranial flap for reconstruction of anterior skull base defects after sino-nasal tumor resection: assessment of postoperative frontal lobe sagging and frontal lobe falling by Fiacchini, G, De Santi, S, Trico, D, Cambi, C, Seccia, V, Cristofani-Mencacci, L, Berrettini, S, Bruschini, L, Scarano, M, Dallan, I

“…The evolution of endoscopic skull base approaches has enabled surgeons to manage selected skull base tumors through a transnasal endoscope-assisted approach…”
Get full text

The impact of triglycerides on glucose tolerance: Lipotoxicity revisited by Seghieri, M., Tricò, D., Natali, A.

“…Elevated plasma triglycerides (TGs) are early key features of conditions associated with a dysregulation in glucose metabolism and may predict the development…”
Get full text

Parameters influencing renal response to SGLT2 inhibitors and GLP1 receptor agonists in type 2 diabetes patients with preserved renal function: a comparative, prospective study by Biancalana, E., Petralli, G., Raggi, F., Distaso, MR, Piazza, G., Rossi, C., Tricò, D., Solini, A.

“…Purpose SGLT2 inhibitors (SGLT2i) and GLP1 receptor agonists (GLP1-RA) protect the kidney in type 2 diabetes (T2DM) subjects. The role of patient’s phenotype…”
Get full text

Sustained effects of a protein and lipid preload on glucose tolerance in type 2 diabetes patients by Tricò, D, Filice, E, Baldi, S, Frascerra, S, Mari, A, Natali, A

“…Abstract Background Small amounts of nutrients given as a ‘preload’ can reduce post-meal hyperglycaemic peaks in type 2 diabetes (T2D) patients by activating a…”
Get full text

Manipulating the sequence of food ingestion improves glycemic control in type 2 diabetic patients under free-living conditions by Tricò, D, Filice, E, Trifirò, S, Natali, A

“…Lipid and protein ingested before carbohydrate reduce postprandial hyperglycemia. We tested feasibility, safety and clinical efficacy of manipulating the…”
Get full text

A short-term increase in dietary cholesterol and fat intake affects high-density lipoprotein composition in healthy subjects by Morgantini, C., Trifirò, S., Tricò, D., Meriwether, D., Baldi, S., Mengozzi, A., Reddy, S.T., Natali, A.

“…High-cholesterol and high-fat diets alter biochemical composition and anti-oxidant properties of high-density lipoproteins (HDL) in animals. Whether this…”
Get full text

Circadian heart rate fluctuations predict 21-year cardiovascular and all-cause mortality in type 2 and type 1 diabetes by Nesti, L, Chiriaco, M, Sacchetta, L, Moriconi, D, Santoni, L, Forotti, G, Chiriaco, G, Natali, A, Solini, A, Trico, D

“…Abstract Background Alterations in circadian heart rate (HR) fluctuations have been associated with cardiovascular events in the general population. This study…”
Get full text

Reducing Cholesterol and Fat Intake Improves Glucose Tolerance by Enhancing β Cell Function in Nondiabetic Subjects by Tricò, Domenico, Trifirò, Silvia, Mengozzi, Alessandro, Morgantini, Cecilia, Baldi, Simona, Mari, Andrea, Natali, Andrea

“…Abstract Context A diet low in cholesterol and fat is commonly recommended to prevent metabolic and cardiovascular diseases; however, its effect on glucose…”
Get full text

P446 INDEPENDENT EFFECTS OF TYPE 2 DIABETES AND OBESITY ON CARDIOPULMONARY PERFORMANCE IN SUBJECTS AT HIGH CARDIOVASCULAR RISK by Nesti, L, Pugliese, N, Armenia, S, De Biase, N, Balletti, A, Tricò, D, Natali, A

“…Abstract Background Both obesity and type 2 diabetes (T2D) are associated with effort intolerance and heart failure. Since the two conditions often coexist and…”
Get full text

AF.47 HOSPITALIZATION FOR DRUG INFUSION DOES NOT INCREASE COVID INFECTION RATE, IBD RELAPSES DUE TO INFECTIONS AND LEVELS OF ANXIETY IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE: A COMPARATIVE STUDY by Bertani, L., Barberio, B., Tricò, D., Zanzi, F., Maniero, D., Ceccarelli, L., Marsilio, I., Minciotti, M., Coppini, F., Lorenzon, G., Mumolo, M.G., Zingone, F., Costa, F., Savarino, E.V.

Get full text

P965 Ulcerative proctitis treated with biologics: is it too hard to treat? by Bertani, L, Tricò, D, Barberio, B, Bretto, E, Ceccarelli, L, Calabrese, F, Pasta, A, Bertin, L, Fabiana, Z, Maniero, D, Frara, S, De Bernardi, A, Bodini, G, Ribaldone, D G, Costa, F, Savarino, E V

“…Abstract Background Patients with ulcerative proctitis are widely considered a challenging population because the reported reduced response rate to…”
Get full text

P576 Fecal calprotectin could predict clinical and endoscopic response to ustekinumab therapy by Bertani, L, Tricò, D, Barberio, B, Vernero, M, Bretto, E, Ceccarelli, L, Pardi, V, Calabrese, F, Pasta, A, Bertin, L, Fabiana, Z, Semprucci, G, Bodini, G, Ribaldone, D G, Savarino, E V, Costa, F

“…Abstract Background Ustekinumab (UST) is one of the most used biologic drugs for the treatment of Crohn’s Disease (CD) and Ulcerative Colitis (UC). However,…”
Get full text